Feb 25 (Reuters) - The U.S. Food and Drug Administration approved on Wednesday Eton Pharmaceuticals' ETON.O oral liquid therapy for a rare childhood hormonal disorder, giving families an easier way to manage the condition and keep children hydrated.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona)
((Kamal.Choudhury@thomsonreuters.com))